| Synergistic Effects of Cabozantinib and EGFR‐Specific CAR‐NK‐92 Cells in Renal Cell Carcinoma Q Zhang, K Tian, J Xu, H Zhang, L Li, Q Fu, D Chai, H Li, J Zheng Journal of immunology research 2017 (1), 6915912, 2017 | 74 | 2017 |
| Post-translational modifications of EZH2 in cancer Z Li, M Li, D Wang, P Hou, X Chen, S Chu, D Chai, J Zheng, J Bai Cell & bioscience 10, 1-13, 2020 | 58 | 2020 |
| Therapeutic cancer vaccines: From biological mechanisms and engineering to ongoing clinical trials N Sobhani, B Scaggiante, R Morris, D Chai, M Catalano, DR Tardiel-Cyril, ... Cancer treatment reviews 109, 102429, 2022 | 54 | 2022 |
| The development of CAR design for tumor CAR-T cell therapy D Xu, G Jin, D Chai, X Zhou, W Gu, Y Chong, J Song, J Zheng Oncotarget 9 (17), 13991, 2018 | 54 | 2018 |
| AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction D Chai, H Shan, G Wang, H Li, L Fang, J Song, J Bai, J Zheng Experimental cell research 370 (2), 561-570, 2018 | 44 | 2018 |
| The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines M Li, X Zhang, Y Lu, S Meng, H Quan, P Hou, P Tong, D Chai, X Gao, ... Cell Death & Disease 11 (1), 31, 2020 | 31 | 2020 |
| Combining DNA Vaccine and AIM2 in H1 Nanoparticles Exert Anti-Renal Carcinoma Effects via Enhancing Tumor-Specific Multi-functional CD8+ T-cell Responses D Chai, H Shan, G Wang, Q Zhang, H Li, L Fang, J Song, N Liu, Q Zhang, ... Molecular cancer therapeutics 18 (2), 323-334, 2019 | 31 | 2019 |
| Mucosal co-immunization with AIM2 enhances protective SIgA response and increases prophylactic efficacy of chitosan-DNA vaccine against coxsackievirus B3-induced myocarditis D Chai, Y Yue, W Xu, C Dong, S Xiong Human Vaccines & Immunotherapeutics 10 (5), 1284-1294, 2014 | 26 | 2014 |
| H1/pAIM 2 nanoparticles exert anti‐tumour effects that is associated with the inflammasome activation in renal carcinoma D Chai, N Liu, H Li, G Wang, J Song, L Fang, Z Lu, H Yao, J Zheng Journal of cellular and molecular medicine 22 (11), 5670-5681, 2018 | 25 | 2018 |
| The Anti-fibrosis drug Pirfenidone modifies the immunosuppressive tumor microenvironment and prevents the progression of renal cell carcinoma by inhibiting tumor autocrine TGF-β G Wang, X Zhou, Z Guo, N Huang, J Li, Y Lv, L Han, W Zheng, D Xu, ... Cancer biology & therapy 23 (1), 150-162, 2022 | 23 | 2022 |
| iNKT: a new avenue for CAR-based cancer immunotherapy Y Liu, G Wang, D Chai, Y Dang, J Zheng, H Li Translational Oncology 17, 101342, 2022 | 23 | 2022 |
| Using PAMPs and DAMPs as adjuvants in cancer vaccines H Sun, W Hu, Y Yan, Z Zhang, Y Chen, X Yao, L Teng, X Wang, D Chai, ... Human Vaccines & Immunotherapeutics 17 (12), 5546-5557, 2021 | 23 | 2021 |
| A fully human monoclonal antibody targeting PD-L1 with potent anti-tumor activity Y Luan, D Chai, J Peng, S Ma, M Wang, H Ma, X Li, S Fu, X Pan, X Wang, ... International Immunopharmacology 31, 248-256, 2016 | 21 | 2016 |
| The next-generation DNA vaccine platforms and delivery systems: Advances, challenges and prospects B Lu, JM Lim, B Yu, S Song, P Neeli, N Sobhani, P K, SR Bonam, ... Frontiers in immunology 15, 1332939, 2024 | 18 | 2024 |
| The optimization system for preparation of TG1 competent cells and electrotransformation D Chai, G Wang, L Fang, H Li, S Liu, H Zhu, J Zheng MicrobiologyOpen 9 (7), e1043, 2020 | 17 | 2020 |
| Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancer J Yang, Y Wei, H Yin, L Fang, D Chai, H Li, H Li, Q Zhang, J Zheng International immunopharmacology 70, 125-134, 2019 | 17 | 2019 |
| AIM2 Co-immunization with VP1 is associated with increased memory CD8 T cells and mounts long lasting protection against coxsackievirus B3 challenge L Yin, D Chai, Y Yue, C Dong, S Xiong Frontiers in Cellular and Infection Microbiology 7, 247, 2017 | 16 | 2017 |
| Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity D Chai, D Qiu, X Shi, J Ding, N Jiang, Z Zhang, J Wang, J Yang, P Xiao, ... Molecular Therapy Oncolytics 24, 1-13, 2022 | 15 | 2022 |
| Absent in melanoma 2-mediating M1 macrophages facilitate tumor rejection in renal carcinoma D Chai, Z Zhang, S yuchen Shi, D Qiu, C Zhang, G Wang, L Fang, H Li, ... Translational Oncology 14 (4), 101018, 2021 | 15 | 2021 |
| ISG12a and its interaction partner NR4A1 are involved in TRAIL‐induced apoptosis in hepatoma cells N Liu, Z Wu, A Chen, D Chai, L Li, L Zhang, J Zheng Journal of Cellular and Molecular Medicine 23 (5), 3520-3529, 2019 | 15 | 2019 |
